Nikon halves imaging time with new integrated microscope
Nikon has launched a new inverted microscope range that promises to more than half the time of an imaging experiment while enabling more simultaneous applications.
Archives for November 1, 2007
Parexel profits perky in Q1
Parexel has seen its profits remain perky during its first financial quarter of 2008.
PPD, Novotech and Generex – Clinical contract news
Outsourcing-Pharma.com compiles the news that featured in the clinical contract community of late, involving PPD, Novotech and Generex.
Genentech Avastin decision 'hard to overlook'
Despite Genentech's recent decision to push out the cut-off date to ban the sale of cancer drug Avastin (bevacizumab) to compounding pharmacies in the US to restrict off-label use, ophthalmologists still find the firm's actions hard to forgive.
Gene Logic drops genomics and name for drug repositioning
After selling of its genomics business to Ocimum Biosolutions, Gene Logic is to change its name to Ore Pharmaceuticals as it looks to mine out new indications for drugs.
Future of satraplatin uncertain
GPC Biotech has met another obstacle in its path towards satraplatin approval after the German company announced disappointing and unexpected results in its Phase III trial.
SCOLR on track for first 12-hour ibuprofen
SCOLR Pharma has initiated the first of three pivotal trials to evaluate its extended release ibuprofen tablet, with hopes that it will be the first and only 12-hour formulation on the market.